PRISMA—Efficacy and Safety of Vedolizumab for Inflammatory Bowel Diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PRISMA—Efficacy and Safety of Vedolizumab for Inflammatory Bowel Diseases

Published:2014-12 Issue:28 Volume:93 Page:e326
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Wang Man Cai,Zhang Ling Yi,Han Wei,Shao Yuan,Chen Mo,Ni Rui,Wang Gen Nian,Wei Feng Xian,Zhang Ya Wu,Xu Xiao Dong,Zhang You Cheng

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference39 articles.

1. Vedolizumab for the treatment of ulcerative colitis and Crohns disease.;McLean;Immunotherapy,2012

2. Novel targets for inflammatory bowel disease therapeutics.;Lowenberg;Curr Gastroenterol Rep,2013

3. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.;Molodecky;Gastroenterology,2012

4. A clinical review of recent findings in the epidemiology of inflammatory bowel disease.;Ponder;Clin Epidemiol,2013

5. Recent developments in the treatment of inflammatory bowel disease.;Rietdijk;J Dig Dis,2013

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biologicals in the prevention and treatment of intestinal graft rejection: The state of the art Biologicals in Intestinal Transplantation;Human Immunology;2024-07

2. Valoración de la transición de vedolizumab intravenoso a subcutáneo en pacientes con enfermedad inflamatoria intestinal;Gastroenterología y Hepatología;2024-05

3. Therapeutic Drug Monitoring as a Tool for the Clinical Outcome Prediction in Vedolizumab-Treated Patients: An Italian Pilot Study;Biomedicines;2024-04-09

4. Vedolizumab for induction and maintenance of remission in Crohn's disease;Cochrane Database of Systematic Reviews;2023-07-17

5. Efficacy and safety of vedolizumab in the treatment of patients with inflammatory bowel disease: A systematic review and meta‑analysis of randomized controlled trials;Experimental and Therapeutic Medicine;2023-05-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3